Lymphoblastic Lymphoma

• CLINICAL_TRIALS trial_result · 2026-06-02
  Clinical Trial Update: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma [Phase 3]

  A Phase 3 trial evaluating levocarnitine for protecting the liver during chemotherapy in various B-cell acute lymphoblastic leukemia and rel…

• CLINICAL_TRIALS trial_result · 2026-02-17
  Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia [Phase 2]

  Phase 2 clinical trial update describing a combination chemotherapy regimen for relapsed or refractory acute lymphoblastic leukemia, lymphob…

• CLINICAL_TRIALS trial_result · 2025-09-30
  Clinical Trial Update: A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL [Phase 1]

  This report summarizes the completion of a Phase 1 study of WU-CART-007, an allogeneic anti-CD7 CAR-T cell therapy, in patients with relapse…

• CLINICAL_TRIALS trial_result · 2025-09-16
  Clinical Trial Update: HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]

  This pediatric Phase 1/2 clinical trial evaluates capivasertib plus venetoclax and dexamethasone for relapsed or refractory hematologic mali…

• CLINICAL_TRIALS trial_result · 2025-08-11
  Clinical Trial Update: Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 1, Phase 2]

  Phase 1/2 trial evaluating tagraxofusp in combination with low-intensity chemotherapy for CD123-positive relapsed or refractory acute lympho…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-06-17
  Clinical Trial Update: PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma [Phase 1, Phase 2]

  This clinical trial update summarizes the Phase 1/2 results of oral ixazomib in combination with chemotherapy for pediatric patients with re…

• CLINICAL_TRIALS trial_result · 2025-03-07
  Clinical Trial Update: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease [Phase 2]

  Phase 2 trial evaluating an umbilical cord blood transplant regimen with cyclophosphamide, fludarabine, and total-body irradiation for hemat…

• CLINICAL_TRIALS trial_result · 2024-12-06
  Clinical Trial Update: Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies [Phase 1]

  Phase 1 clinical trial studying tagraxofusp in pediatric patients with CD123-expressing hematologic malignancies is currently recruiting, sp…

• CLINICAL_TRIALS trial_result · 2024-08-16
  Clinical Trial Update: Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) [Phase 1]

  Phase 1 trial results evaluate palbociclib in combination with chemotherapy for pediatric patients with relapsed acute lymphoblastic leukemi…

• CLINICAL_TRIALS trial_result · 2024-07-30
  Clinical Trial Update: A Study of PD5K3 in Healthy Adult Volunteers [Phase 1]

  Phase 1 clinical trial update for PD5K3 in healthy adult volunteers; the study has completed and investigated safety and pharmacokinetics. C…

• CLINICAL_TRIALS trial_result · 2024-06-27
  Clinical Trial Update: BeFluBu vs FluBuRux Conditioning in Haploidentical HCT [Phase 2]

  Phase 2 clinical trial comparing BeFluBu vs FluBuRux conditioning regimens in haploidentical stem cell transplantation is currently recruiti…

• CLINICAL_TRIALS trial_result · 2024-05-07
  Clinical Trial Update: Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) [Phase 2]

  This Phase 2 clinical trial update reports on conditioning with benadamustine, fludarabine, and busulfan (FluBuBe) for recipients of haploid…

• CLINICAL_TRIALS trial_result · 2023-11-18
  Clinical Trial Update: An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) [Phase 2, Phase 3]

  Open-label study of JZP-458 (RC-P) in acute lymphoblastic leukemia and lymphoblastic lymphoma completed; results posted in 2023.

• CLINICAL_TRIALS trial_result · 2023-10-31
  Clinical Trial Update: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma [Phase 2]

  Phase 2 trial investigating BL-8040 with nelarabine for relapsed/refractory T-ALL and T-ALL/LBL was terminated; results posted.

• CLINICAL_TRIALS trial_result · 2023-10-13
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

  Phase 2 study evaluating daratumumab for relapsed/refractory precursor B-cell or T-cell acute lymphoblastic leukemia and lymphoblastic lymph…

• CLINICAL_TRIALS trial_result · 2023-09-21
  Clinical Trial Update: Allo HSCT Using RIC for Hematological Diseases [Phase 2]

  Phase 2 trial evaluating allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for various hematologic dise…

• CLINICAL_TRIALS trial_result · 2023-07-27
  Clinical Trial Update: A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma [Phase 1]

  Phase 1 trial evaluating temsirolimus with etoposide and cyclophosphamide in children with relapsed acute lymphoblastic leukemia and non-Hod…

• CLINICAL_TRIALS trial_result · 2022-10-28
  Clinical Trial Update: Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL [Phase 2]

  Phase 2 clinical trial evaluating a Modified TBF conditioning regimen before allogeneic stem cell transplant in T-ALL/LBL.

• CLINICAL_TRIALS trial_result · 2022-10-25
  Clinical Trial Update: Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia [Phase 1, Phase 2]

  Phase 1/2 trial evaluating mitoxantrone with clofarabine for recurrent non-Hodgkin lymphoma or acute leukemia has completed.

• CLINICAL_TRIALS trial_result · 2022-09-21
  Clinical Trial Update: Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 clinical trial evaluating a fludarabine and total body irradiation regimen as conditioning for allogeneic hematopoietic cell transpl…

• CLINICAL_TRIALS trial_result · 2022-09-10
  Clinical Trial Update: SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma [Phase 2]

  This Phase 2 trial compares SC-PEG Asparaginase to Oncaspar in pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma, with resul…

• CLINICAL_TRIALS trial_result · 2022-08-19
  Clinical Trial Update: Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults [Phase 4]

  Phase 4 clinical trial update for newly diagnosed mature B-ALL, Burkitt's lymphoma, and other high-grade lymphomas in adults has completed.

• CLINICAL_TRIALS trial_result · 2022-07-13
  Clinical Trial Update: Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

  Phase 2 trial evaluating a multi-agent regimen (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin) for Acute Lymphoblastic L…

• CLINICAL_TRIALS trial_result · 2022-05-23
  Clinical Trial Update: NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma [Phase 2]

  Phase 2 trial update for newly diagnosed lymphoblastic lymphoma (adult/child) completed with posted results.

• CLINICAL_TRIALS trial_result · 2021-12-14
  Clinical Trial Update: Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma [Phase 1, Phase 2]

  Phase 1 and Phase 2 trial update for ruxolitinib and chidamide in acute T cell lymphoblast leukemia/lymphoblastic lymphoma ongoing; current …